Close

More on LLY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+51.9% Growth)
- Ratings (7.3 Score)
- Holders
- Dividends (0.6% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/30/24)
- M&A (12/31/22 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

LLY Balance Sheet

Click line-items for a historical chart and %
Current Assets
Cash and cash equivalents 3.49B
Short-term investments 737.8M
Accounts receivable, net of allowances of $116.0 (2011) and $100.4 (2010) 3.85B
Other receivables
Inventories 3.88B
Prepaid taxes
Prepaid expenses and other 756.5M
Total current assets 13.39B
Other Assets
Investments 5.03B
Goodwill and other intangibles - net
Sundry 2.28B
Total other assets 15.95B
Property and Equipment
Land, buildings, equipment, and construction-in-progress 17.24B
Less accumulated depreciation -8.99B
Land, buildings, equipment, and construction-in-progress, net 8.25B
Total assets 37.59B
Current Liabilities
Short-term borrowings
Accounts payable 1.16B
Employee compensation 738.5M
Sales rebates and discounts 3.55B
Dividends payable 0
Income taxes payable 183M
Other current liabilities 2B
Total current liabilities 8.27B
Other Liabilities
Long-term debt 8.71B
Accrued retirement benefit 2.08B
Long-term income taxes payable 805.6M
Other noncurrent liabilities 2.11B
Total noncurrent liabilities 13.7B
Shareholders' Equity
Common stock 690.4M
Additional paid-in capital 5.65B
Retained earnings 16.6B
Employee benefit trust -3.01B
Deferred costs-ESOP
Accumulated other comprehensive loss -4.26B
Noncontrolling interests 26.6M
Shareholders' equity, including treasury shares
Less cost of common stock in treasury -80.5M
Total shareholders' equity 15.62B
Total liabilities and shareholders' equity 37.59B